Skip to main content

Nukkleus Inc

For the period ended Sep 30, 2023. Filed Jul 12, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Jul 12, 2024

DFNS$1.95-3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NUKKLEUS INC.
Dated: July 11, 2024By:/s/ Emil Assentato
Emil Assentato
Chief Executive Officer (Principal Executive Officer), and Chief Financial Officer (Principal Financial and Accounting Officer), and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.

SignatureTitleDate
/s/ Emil AssentatoChief Executive Officer (Principal Executive Officer), Chief FinancialJuly 11, 2024
Officer (Principal Financial Officer), and Chairman
/s/ Jamal “Jamie” KhurshidChief Operating Officer and DirectorJuly 11, 2024
/s/ Nicholas GregoryDirectorJuly 11, 2024
/s/ Daniel MarcusDirectorJuly 11, 2024
/s/ Brian SchwiegerDirectorJuly 11, 2024
/s/ Reuven YeganehDirectorJuly 11, 2024
/s/Anastasiia KotaievaDirectorJuly 11, 2024
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.